No Detail Found!

Correlation of Intraocular Pressure with Ocular Axial Length after Intravitreal Injection of Bevacizumab in Diabetic Macular Edema.

Author(s)
Sumayya Khan Armed Forces Institute of Ophthalmology (AFIO), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Ahsan Mukhtar Armed Forces Institute of Ophthalmology (AFIO), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Mazhar Ishaq Armed Forces Institute of Ophthalmology (AFIO), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Rana Intisar Ul Haq Armed Forces Institute of Ophthalmology (AFIO), National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Abstract
Objective: To determine the effect of Intravitreal injection of Bevacizumab on IOP in eyes of different axial lengths. Study Design: Cross sectional study. Place and Duration of Study: This study was conducted at AFIO Rawalpindi, from Sep 2013 to Jan 2014. Material and Methods: In this study 55 patients scheduled for intravitreal injection of bevacizumab for the treatment of diabetic macular edema were enrolled. An informed written consent was taken from all the patients. All patients underwent clinical ophthalmic examination including uncorrected distance visual acuity, corrected distance visual acuity, slit lamp bio-microscopy and fundus examination with 90 diopter lens. Axial length was measured before IVB using IOL master. Intra Ocular Pressure (IOP) was measured before and after 1 minute of administration of Intravitreal Bevacizumab (IVB) using Tono-Pen. Result: The mean age of patients was 54.51 ± 7.53 years with minimum age of 43 years and maximum age of 70 years. There were 26 (47.3%) male and 29 (52.7%) female patients. The mean axial length of the examined eyes was 21.12 ± 1.80 with range of 6 mm. Mean IOP before IVB was 13.09 ± 1.62 mmHg. After 1 minute of IVB, mean IOP was 32.8 ± 6.19 mmHg. A good correlation was observed between the axial length and intraocular pressure rise after 1 min i.e. Pearson correlation (r.) = -0.914 (p-value <0.001) with R2 = 0.835. Conclusion: There is significant rise in IOP after intravitreal injection of bevacizumab in patients with short axial length as compared to long axial length.
Publication Details
Page(s) 515-520
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 3, Year: 2018

Request the full text from PASTIC

References
AzadR,SainS,SharmaYR,MahajanD, 2012.Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study,Oman J Ophthalmol 5 166 -
BakriSJ,PulidoJS,McCannelCA,HodgeDO,DiehlN,HillemeierJ, 2009.Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab,Eye 23 181 -5
BenzMS,AlbiniTA,HolzER, 2006.Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide,Ophthalmology 113 1174 -78
BoonCJ,CramaN,KleveringBJ,van KuijkFJ,HoyngCB, 2008.Reflux after intravitreal injection of bevacizumab,Ophthalmology 115 1270 -
CacciamaniA,OddoneF,ParravanoM,ScarinciF,Di NicolaM,LofocoG, 2013.Intravitreal injection of bevacizumab: Changes in intraocular pressure related to ocular axial length,Jpn J Ophthalmol 57 63 -7
CioboataM,AnghelieA,ChiotanC,LioraR,SerbanR,CornăcelC, 2014.Benefits of anterior chamber paracentesis in the management of glaucomatous emergencies,J Med Life 7 5 -6
DehghaniA,JafariH,Shoeibi N, 2014.Short-term intraocular pressure changes after intravitreal bevacizumab injection,Reviews in Clinical Medicine 1 93 -6
DingJ,WongTY, 2012.Current epidemiology of diabetic retinopathy and diabetic macular edema,Current diabetes reports 12 346 -54
DwingerMC,Pieper-BodeewesI,EterN,HolzFG, 2005.Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection,Klin Monbl Augenheilkd 222 638 -42
FalavarjaniKG,NguyenQD, 2013.Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature,Eye 27 787 -94
FalkensteinIA,ChengL,FreemanWR, 2007.Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin),Retina 27 1044 -7
FarhoodQK,TwfeeqSM, 2014.Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients,Clinical Ophthalmology (Auckland, NZ) 8 599 -604
FossAJ,ScottLJ,RogersCA,ReevesBC,GhanchiF,GibsonJ, 2015.Changes in intraocular pressure in study and fellow eyes in the IVAN trial,Br J Ophthalmol -
FurlaniBA,MeyerCH,RodriguesEB,MaiaM,FarahME,PenhaFM, 2007.Emerging pharmacotherapies for diabetic macular edema,Expert opinion on emerging drugs 12 591 -603
GismondiM,SalatiC,SalvetatML,ZeppieriM,BrusiniP, 2009.Shortterm effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure,J Glaucoma 18 658 -61
GoktasA,GoktasS,AtasM, 2013.Short-term impact of intravitreal ranibizumab injection on axial ocular dimension and intraocular pressure,Cutan Ocul Toxicol 32 23 -6
HoangQV,TsuangAJ,GelmanR,MendoncaLS,Della TorreKE,JungJJ, 2013.Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy,Retina 33 179 -87
HollandsH,WongJ,BruenR,CampbellRJ,SharmaS,GaleJ, 2007.Short-term intraocular pressure changes after intravitreal injection of bevacizumab,Can J Ophthalmol /Journal Canadien d' Ophtalmologie 42 807 -11
KimJE,MantravadiAV,HurEY,CovertDJ, 2008.Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents,Am J Ophthalmol 146 930 -4
KimGN,HanYS,ChungIY,SeoSW,ParkJM,YooJM, 2013.Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension,In Seminars in ophthalmology 28 61 -67
KotliarK,MaierM,BauerS,FeuchtN,LohmannC,LanzlI, 2007.Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model,Acta Ophthalmologica Scandinavica 85 77781 -
LeeJW,ParkH,ChoiJH,LeeHJ,MoonSW,KangJH, 2016.Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab,BMC ophthalmology 16 1 -
Lemos-ReisR,Moreira-GonçalvesN,MeloAB,CarneiroÂM,Falcão-ReisFM, 2014.Immediate effect of intravitreal injection of bevacizumab on intraocular pressure. Clinical ophthalmology (Auckland, 8 1383 -
MareyHM,EllakwaAF, 2011.Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema,Clin Ophthalmol [Internet] 5 1011 -6
MojicaG,HariprasadSM,JagerRD,MielerWF, 2008.Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration,Br J Ophthalmol 92 584 -
MathaloneN,Arodi-GolanA,SarS,WolfsonY,ShalemM,LaviI, 2012.Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration,Ger J Ophthalmol 250 1435 -40
Popa-CherecheanuA,IancuRC,SchmettererL,PirvulescuR,CoviltirV.,IntraocularPressure, 2017.Refractive Changes after Phacoemulsification and Trabeculectomy for Open-Angle Glaucoma,J Ophthalmol 1203269 -
ReadSA,CollinsMJ,Annis-BrownT,HaywardNM,LillymanK,SherwinD,StockallP., 2011.The short-term influence of elevated intraocular pressure on axial length,Ophthalmic Physiol Opt 31 398 -403
SoheilianM,KarimiS,MontahaeT,NikkhahH,MosaviSA, 2017.Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: A prospective study,Graefes Arch Clin Exp Ophthalmol 255 1705 -12
0

Citations

0

Downloads

108

Views